Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 17, 2015Molecular CancerOpen Access

Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJana LinhartováInstitute of Haematology and Blood TransfusionLHLenka HovorkováCharles UniversitySSSimona SoveriniIstituto Oncologico Romagnolo

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Linhartová et al. (2015) studied this question.

synapsesocial.com/papers/6a9df020dff2fec06dacb027https://doi.org/10.1186/s12943-015-0363-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of Variant TMPRSS2/ERG Fusion Messenger RNAs Is Associated with Aggressive Prostate Cancer2006 · 416 citations
  2. 2Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease2013 · 420 citations
  3. 3Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR‐ABL DNA2010 · 57 citations
  4. 4Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study2013 · 721 citations